An Act relative to increased availability of opioid antagonist medication
House: Accompanied a study order, see H5234
Email me when H 2404 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track H 2404. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill directs the department to issue regulations that require every Commonwealth agency and board to keep opioid‑antagonist medication on hand and to train their employees on its use each year. It also asks the department to provide non‑mandatory guidance to private employers on acquiring the medication and conducting annual training. The purpose is to broaden access to life‑saving overdose‑reversal drugs.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about H 2404
3 free questions a day, no accountHearings
- Public Health hearing on legislation related to disease prevention, screening, and treatment, and pharmacies.Joint Committee on Public Health · Jun 11, 2025
History
- Accompanied a study order, see H5234
- Reporting date extended to Thursday, October 9, 2025
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Senate concurred
- Referred to the committee on Public Health
Sponsors
- Kate Donaghue · sponsor
- Angelo J. Puppolo, Jr.
- Carmine Lawrence Gentile
- Kristin E. Kassner
- Vanna Howard
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when H 2404 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track H 2404 freeOr ask your AI assistant about H 2404 directly:
Add to Claude, ChatGPT or Cursor